Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19.
Maslennikov R, Ivashkin V, Vasilieva E, Chipurik M, Semikova P, Semenets V, Russkova T, Levshina A, Grigoriadis D, Magomedov S, Efremova I, Dzhakhaya N.
Maslennikov R, et al.
Pulm Pharmacol Ther. 2021 Aug;69:102039. doi: 10.1016/j.pupt.2021.102039. Epub 2021 May 21.
Pulm Pharmacol Ther. 2021.
PMID: 34023513
Free PMC article.
Clinical Trial.